[go: up one dir, main page]

TW201144289A - Novel process for the preparation of piperazine compounds and hydrochloride salts thereof - Google Patents

Novel process for the preparation of piperazine compounds and hydrochloride salts thereof Download PDF

Info

Publication number
TW201144289A
TW201144289A TW099143483A TW99143483A TW201144289A TW 201144289 A TW201144289 A TW 201144289A TW 099143483 A TW099143483 A TW 099143483A TW 99143483 A TW99143483 A TW 99143483A TW 201144289 A TW201144289 A TW 201144289A
Authority
TW
Taiwan
Prior art keywords
formula
compound
aryl
bicyclic
optionally substituted
Prior art date
Application number
TW099143483A
Other languages
Chinese (zh)
Inventor
Laszlo Czibula
Balint Juhasz
Csongor Eva Againe
Ferenc Sebok
Janos Galambos
Katalin Nogradi
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of TW201144289A publication Critical patent/TW201144289A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a new process for the preparation of compounds of general formula (I) wherein R1 and R2 represent independently hydrogen or C1-6 alkyl with straight or branched chain optionally substituted with aryl group, or C2-7 alkenyl containing 1-3 double bonds, or monocyclic, bicyclic or tricyclic aryl optionally substituted with one or more C1-6 alkoxy, trifluoro-C1-6 alkoxy, C1-6-alkoxycarbonil, C1-6alkanoyl, aryl, C1-6 alkylthio, halogen or cyano, or optionally substituted monocyclic, bicyclic or tricyclic C3-14 cycloalkyl group, R1 and R2 together with the adjacent nitrogen form a saturated or unsaturated optionally substituted monocyclic or bicyclic heterocyclic ring which may contain further heteroatoms selected from oxygen, nitrogen, or sulphur atoms and hydrochloric acid salts and/or hydrates and/or solvates thereof, by dissolving or suspending trans 4-{2-[4-(2, 3-dichlorophenyl)-piperazine-1-il]-ethyl}-cyclohexylamine of formula (III) or a salt or a hydrate or a solvate thereof in an inert solvent in the presence of a base then adding a carbonic acid derivative of general formula (VI) wherein R is alkyl with C1-6 straight or branched chain, partially or fully halogenated C1-2 alkyl or phenyl, Z is -O-R or -X, wherein R is as described above, X is halogen, and reacting the compound of general formula (IV) obtained wherein R is as described above, in situ or, optionally in isolated state with an amine of general formula (V) wherein R1 and R2 are as described above to obtain the compound of general formula (I) and then optionally forming the hydrochloride salts and/or hydrates and/or solvates thereof.

Description

201144289 六、發明說明 【發明所屬之技術領域】 本發明關於一種製備通式(I)之反式N-{4-p-t4-(2,3-一氯本基)-峨哄-1-基]•乙基}•環己基卜尿素化合物及其鹽 酸鹽及/或水合物及/或溶劑合物的新穎方法,201144289 VI. Description of the Invention [Technical Field to Which the Invention Is Ascribed] The present invention relates to a preparation of trans N-{4-p-t4-(2,3-chlorobenyl)-fluorene-1- of the general formula (I) Novel method for the hydroxy group of the cyclohexyl bromide compound and its hydrochloride and/or hydrate and/or solvate,

其中Ri及R2獨立代表 -氫,或 -以芳基隨意地取代之直鏈或支鏈Cl_6烷基,或 -R!及R2與鄰接的氮—起可形成隨意地經取代之 飽和或不飽和單環或雙環雜環狀環,其可含有選自氧、氮 或硫原子之另外的雜原子, -含有1-3個雙鍵之C2-7烯基,或 -以一或多個Cl6烷氧基、三氟-Ci6烷氧基、Wherein Ri and R2 independently represent -hydrogen, or - a linear or branched Cl-6 alkyl group optionally substituted with an aryl group, or -R! and R2 together with an adjacent nitrogen may form an optionally substituted saturated or unsaturated Monocyclic or bicyclic heterocyclic rings which may contain additional heteroatoms selected from oxygen, nitrogen or sulfur atoms, - C2-7 alkenyl groups containing 1-3 double bonds, or - one or more Cl6 alkanes Oxy, trifluoro-Ci6 alkoxy,

Cm垸氧基锻基、Cl 6烷醯基、芳基、Ci 6烷硫基、氰基 或鹵素原子隨意地取代之單環、雙環或三環芳基, -隨意地經取代之單環、雙環或三環c3_14環烷 201144289 【先前技術】 通式(I)化合物的鹼形式原來揭示於匈牙利專利說明 書(Hungarian Patent Specification)第 P030245 1 號中》在 說明書中提供三種反應途徑(A、B、C方法)來製備式(I)化 合物的鹼形式。在方法"中,將適合的胺與(硫代)胺 甲醯基氯反應’得到通式(I)之最終產物。根據P030245 1 的A方法’ '' A 〃程序僅得到6 5 %產率之產物且以非常長 的反應時間。根據方法B,將異(硫代)氰酸酯與胺化合物 反應。〃方法的缺點是使用此程序僅可製備其中1及 R2基團代表氫的通式(I)化合物。根據P0302451的"C" 方法,將適合的胺轉變成異(硫代)氰酸酯衍生物,接著將 此異(硫代)氰酸酯衍生物與胺反應,得到式(I)之所欲最終 產物。方法C的總產率非常低,僅52%而已。 A〃及a C〃程序的缺點是長的反應時間(48及20 小時)及差的產率(65%及52%)。此外,在"A"及"C" 程序中,所獲得的最終產物應以額外的純化(再結晶)步驟 純化,以得到適當品質的產物。 【發明內容】 吾等的目標係發展出一種提供具有極佳產率的未經取 代與經單取代及經二取代的通式(I)之尿素化合物的方 法。 吾等驚訝地發現藉由將式(II1)之反式4_ {2-[4-(2,3·二 氯苯基)-哌哄-1-基]-乙基}-環己胺或其鹽及/或水合物及/ 201144289 或溶劑合物a monocyclic, bicyclic or tricyclic aryl group optionally substituted by Cm oxime forging group, Cl 6 alkyl fluorenyl group, aryl group, Ci 6 alkylthio group, cyano group or halogen atom, - optionally substituted monocyclic ring, Bicyclic or tricyclic c3_14 cycloalkane 201144289 [Prior Art] The base form of the compound of formula (I) was originally disclosed in Hungarian Patent Specification No. P030245 No. 1 provides three reaction pathways in the specification (A, B, Method C) to prepare the base form of the compound of formula (I). In the method ", a suitable amine is reacted with (thio)amine formazanyl chloride to give the final product of formula (I). According to the A method ' ' ' A 〃 procedure of P030245 1 , only a product of 65% yield was obtained with a very long reaction time. According to Method B, the iso(thio)cyanate is reacted with an amine compound. A disadvantage of the oxime process is that only compounds of the formula (I) wherein the 1 and R2 groups represent hydrogen can be prepared using this procedure. Conversion of a suitable amine to an iso(thio)cyanate derivative according to the "C" method of P0302451, followed by reaction of the iso(thio)cyanate derivative with an amine to give a solution of formula (I) Want the final product. The overall yield of Method C was very low, only 52%. The disadvantages of the A〃 and a C〃 procedures are long reaction times (48 and 20 hours) and poor yields (65% and 52%). In addition, in the "A" &"C" procedures, the final product obtained should be purified in an additional purification (recrystallization) step to give the product of the appropriate quality. SUMMARY OF THE INVENTION Our object is to develop a process for providing unsubstituted and monosubstituted and disubstituted urea compounds of formula (I) with excellent yields. We have surprisingly found that by trans 4_ {2-[4-(2,3·dichlorophenyl)-piperidin-1-yl]-ethyl}-cyclohexylamine of the formula (II1) or Salt and / or hydrate and / 201144289 or solvate

與通式(VI)之碳酸衍生物反應 R-O-CO-Z (VI) 其中R爲直鏈或支鏈烷基、部分或完全鹵化之 Cu烷基或苯基,Z爲-0-R或-X,其中R係如上所述,X 爲鹵素, 接著將所獲得的通式(IV)化合物Reaction with a carbonic acid derivative of the formula (VI) RO-CO-Z (VI) wherein R is a linear or branched alkyl group, a partially or fully halogenated Cu alkyl group or a phenyl group, and Z is -0-R or - X, wherein R is as described above, X is a halogen, and then the obtained compound of the formula (IV) is obtained

RR

(IV) (其中R係如上所述)與通式(V)之胺衍生物反應(IV) (wherein R is as described above) is reacted with an amine derivative of the formula (V)

RiRi

NH / R2 (V) 其中Ri及R2獨立代表 -氫,或 201144289 -以芳基隨意地取代之直鏈或支鏈C^6烷基,或 -含有1-3個雙鍵之C2.7烯基,或 -以一或多個Ci-6院氧基、二氟- Ci-6院氧基、NH / R2 (V) wherein Ri and R2 independently represent -hydrogen, or 201144289 - a linear or branched C^6 alkyl group optionally substituted with an aryl group, or a C2.7 olefin having 1-3 double bonds Or, in the presence of one or more Ci-6 alkoxy, difluoro-Ci-6,

Cu烷氧基羰基、C,_6烷醯基、芳基、(^·6烷硫基、鹵素 或氰基隨意地取代之單環、雙環或三環芳基,或 -隨意地經取代之單環、雙環或三環C3. , 4環烷 基,或 -I及r2與鄰接的氮·一起可形成隨意地經取代之 飽和或不飽和單環或雙環雜環狀環,其可含有選自氧、氮 或硫原子之另外的雜原子, 吾等得到具有非常高產率的通式(I)化合物a monocyclic, bicyclic or tricyclic aryl group optionally substituted by Cu alkoxycarbonyl, C,-6 alkylalkyl, aryl, (6. 6 alkylthio, halogen or cyano, or optionally substituted Ring, bicyclic or tricyclic C3., 4-cycloalkyl, or -I and r2 together with adjoining nitrogen may form a randomly substituted saturated or unsaturated monocyclic or bicyclic heterocyclic ring which may be selected from Additional heteroatoms of oxygen, nitrogen or sulfur atoms, we have obtained compounds of the general formula (I) with very high yield

其中R!及R2係如上所述。 本發明的詳細說明 本發明係關於一種製備通式(I)化合物及其鹽酸鹽及/ 或水合物及/或溶劑合物的新穎方法 201144289Wherein R! and R2 are as described above. DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel process for the preparation of compounds of the general formula (I) and their hydrochlorides and/or hydrates and/or solvates 201144289

其中11!及r2獨立代表 -氫,或 -以芳基隨意地取代之直鏈或支鏈<^_6烷基,或 -含有1-3個雙鍵之C2-7烯基,或 -以一或多個(^_6烷氧基、三氟-Cw烷氧基、 C,-6烷氧基羰基、Cm烷醯基、芳基、Cm烷硫基、鹵素 或氰基隨意地取代之單環、雙環或三環芳基,或 •隨意地經取代之單環、雙環或三環C3.14環烷 基,或 -Ri及h與鄰接的氮一起可形成隨意地經取代之飽和 或不飽和單環或雙環雜環狀環,其可含有選自氧、氮或硫 原子之另外的雜原子。 在Rl及R2的意義中’芳基代表例如苯基、甲苯基、 萘基或菲基。 在進行根據本發明的方法時,將式(ΙΠ)之反式4_{2_ [4-(2,3-一氯本基)-哌哄_丨_基卜乙基卜環己胺或其鹽或水合 物或溶劑合物 -9- 201144289 h2nWherein 11! and r2 independently represent -hydrogen, or - a straight or branched <^_6 alkyl group optionally substituted with an aryl group, or a C2-7 alkenyl group having 1-3 double bonds, or - One or more (^_6 alkoxy, trifluoro-Cw alkoxy, C, -6 alkoxycarbonyl, Cm alkanoyl, aryl, Cm alkylthio, halogen or cyano optionally substituted a cyclic, bicyclic or tricyclic aryl group, or an optionally substituted monocyclic, bicyclic or tricyclic C3.14 cycloalkyl group, or -Ri and h together with an adjacent nitrogen may form an optionally substituted saturated or unsubstituted a saturated monocyclic or bicyclic heterocyclic ring which may contain additional heteroatoms selected from oxygen, nitrogen or sulfur atoms. In the sense of R1 and R2, 'aryl represents for example phenyl, tolyl, naphthyl or phenanthryl In carrying out the process according to the invention, trans 4_{2_[4-(2,3-chlorobenyl)-piperidinyl-p-butylethylcyclohexylamine or its salt of formula (ΙΠ) or Hydrate or solvate-9- 201144289 h2n

(III) 在鹼的存在下溶解或懸浮在惰性溶劑中及與通式(VI)之碳 酸衍生物反應 R-O-CO-Z (VI) 其中R爲直鏈或支鏈C,_6烷甚、部分或完全齒化之 院基或苯基’ Z爲-0-R或-X ’其中R係如上所述,X爲 鹵素, 得到通式(IV)化合物(III) dissolved or suspended in an inert solvent in the presence of a base and reacted with a carbonic acid derivative of the formula (VI) RO-CO-Z (VI) wherein R is a linear or branched C, -6 alkane, part Or fully dentated or phenyl 'Z is -0-R or -X ' wherein R is as described above and X is halogen to give a compound of formula (IV)

其中尺爲Ci-6烷基或完全鹵化之c,.2烷基。接著將所獲 得的通式(IV)化合物與通式(V)之胺反應Wherein the caliper is a Ci-6 alkyl group or a fully halogenated c,.2 alkyl group. The obtained compound of the formula (IV) is then reacted with an amine of the formula (V)

NH / R2 (其中I及r2係如上所述),得到通式(I)化合物。上述反 應可在惰性溶劑中當場進行或在分離通式(IV)化合物之後 進行。 -10- 201144289 可用於根據本發明的方法中之適合的溶劑包括與水不 混溶之惰性溶劑,例如甲苯、二氯甲烷、氯苯或二甲苯。 在本發明較佳的具體例中,溶劑爲二氯甲烷。 可用於根據本發明的方法中之適合的鹼包括有機鹼, 較佳爲三級鹼,例如三乙胺。 在通式(VI)之碳酸衍生物的取代基意義中,當R代表 部分鹵化之烷基時,則烷基可爲例如氯甲基或氯乙基,而 當R代表完全鹵化之烷基時,則烷基可爲例如三氯甲基或 五氯乙基。在本發明較佳的具體例中,碳酸衍生物爲氯甲 酸酯或雙-三氯甲基碳酸酯。 在進行根據本發明的方法時,在通式(IV)與(V)化合 物之間的反應可以在分離步驟之後的此一方式進行,將通 式(IV)之胺基甲酸酯化合物與通式(V)之胺反應。然而, 由於通式(IV)化合物差的分離性,使上述反應較佳地可以 適當的通式(V)之胺添加至式(III)與(VI)之反應混合物中 的此一方式當場在惰性溶劑中進行。在此後者的情況中, 吾等係從式(III)化合物開始,經由未分離之通式(IV)化合 物得到超過90%之高產率的通式(I)化合物。 按照技術文獻,根據本發明的方法之優點如下··產率 從52-6 5 %增加至95%,及藉由使用此程序獲得經N-單取 代之式(I)化合物以外’亦可獲得經N-二取代之化合物。 本發明係關於一種製備通式⑴之反式N-{4-{2-[4-(2,3-二氯苯基)-峨哄_1_基]-乙基}-環己基}-尿素驗及其鹽 酸鹽。 -11 - 201144289 在得到通式(I)之反式N-{4-{2-[4-(2,3-二氯苯基)-哌 哄-1-基]-乙基卜環己基尿素鹼之本發明的具體例中,反 應混合物的處理係以在水性稀釋之後的此一方式進行,將 反應混合物以有機溶劑萃取且式(1)之鹼化合物可以已知 的方式分離’較佳地藉由移除溶劑。 在本發明較佳的具體例中,不將鹼分離,但是在水性 稀釋之後’將反應混合物以氫氯酸酸化至pH 2_4,接著將 反應混合物藉由蒸餾而轉換成水性懸浮液且分離出具有高 純度及超過90 %產率之通式化合物的鹽酸鹽。 【實施方式】 本發明係以下列的非限制性實例加以說明。 實例1 反式Ν·(4-{2-[4-(2,3-二氯苯基)-哌畊-1-基]-乙基卜環 己基)-胺基甲酸甲酯 將ό.45公克(〇.〇丨5莫耳)式(111)化合物之二鹽酸鹽添 加至125毫升二氯甲烷與丨2.25毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於2 0 - 2 5 °C之溫度下攪拌1小 時。將因此獲得的懸浮液添加至介於5-10 °C之溫度下於 25毫升二氯甲烷中的2.3毫升(〇.〇3莫耳)氯甲酸甲酯之溶 液中。將所獲得的反應混合物在介於20-25<t之溫度下攪 拌3小時’接著以3x150毫升(150公克)蒸餾水萃取。將 有機相在真空中蒸發且將殘餘物從甲醇再結晶。在此方式 -12- 201144289 中獲得4·5公克標題產物。 產率:7 2 % 熔點:1 4 3 - 1 4 7。(: 實例2 反式 N-(4-{2-[4-(2,3-二氯苯基哌哄-1-基] 己基)-胺基甲酸異丙酯 將6.45公克(0.015莫耳)式(111)化合物之二留 加至125毫升二氯甲烷與12·25毫升三乙胺的混爸 將所獲得的濃稠懸浮液在介於2〇_25°c之溫度下攪 時。將懸浮液添加至介於5-1〇它之溫度下於30· 中的3.7公克(〇.〇3莫耳)氯甲酸異丙酯之溶液中。 混合物在介於20-25 °C之溫度下攪拌3小時且接 150毫升(150公克)蒸餾水萃取。將有機相在真空 且將所獲得的殘餘物從異丙醇再結晶。在此方式 4.4公克標題化合物。 產率:6 7 %NH / R2 (wherein I and r2 are as described above) gives the compound of the formula (I). The above reaction can be carried out in situ in an inert solvent or after separation of the compound of the formula (IV). -10- 201144289 Suitable solvents which can be used in the process according to the invention include inert solvents which are immiscible with water, such as toluene, dichloromethane, chlorobenzene or xylene. In a preferred embodiment of the invention, the solvent is dichloromethane. Suitable bases for use in the process according to the invention include organic bases, preferably tertiary bases such as triethylamine. In the meaning of the substituent of the carbonic acid derivative of the formula (VI), when R represents a partially halogenated alkyl group, the alkyl group may be, for example, a chloromethyl group or a chloroethyl group, and when R represents a completely halogenated alkyl group. The alkyl group can be, for example, trichloromethyl or pentachloroethyl. In a preferred embodiment of the invention, the carbonic acid derivative is chloroformate or bis-trichloromethyl carbonate. In carrying out the process according to the invention, the reaction between the compounds of the formulae (IV) and (V) can be carried out in this manner after the separation step, with the urethane compound of the formula (IV) Amine reaction of formula (V). However, due to the poor separation of the compound of the formula (IV), the above reaction is preferably carried out in such a manner that an appropriate amine of the formula (V) is added to the reaction mixture of the formulae (III) and (VI). It is carried out in an inert solvent. In the latter case, we have obtained a compound of the formula (I) in a high yield of more than 90% via the unseparated compound of the formula (IV) starting from the compound of the formula (III). According to the technical literature, the advantages of the process according to the invention are as follows: • the yield is increased from 52-6 5 % to 95%, and by obtaining an N-monosubstituted compound of the formula (I) by using this procedure, An N-disubstituted compound. The present invention relates to a preparation of trans N-{4-{2-[4-(2,3-dichlorophenyl)-indol-1-yl]-ethyl}-cyclohexyl}- of the formula (1) Urea test and its hydrochloride. -11 - 201144289 The trans-N-{4-{2-[4-(2,3-dichlorophenyl)-piperidin-1-yl]-ethylb-cyclohexyl urea of the general formula (I) is obtained. In the specific example of the present invention, the treatment of the reaction mixture is carried out in such a manner after aqueous dilution, the reaction mixture is extracted with an organic solvent and the alkali compound of the formula (1) can be isolated in a known manner. By removing the solvent. In a preferred embodiment of the invention, the base is not separated, but after aqueous dilution, the reaction mixture is acidified to pH 2 - 4 with hydrochloric acid, and then the reaction mixture is converted to an aqueous suspension by distillation and separated The hydrochloride salt of the general formula of high purity and over 90% yield. [Embodiment] The present invention is illustrated by the following non-limiting examples. Example 1 Trans-(4-{2-[4-(2,3-dichlorophenyl)-piped-1-yl]-ethylcyclohexyl)-carbamic acid methyl ester will be ό.45 The gram of the compound (111) dihydrochloride of the compound (111) was added to a mixture of 125 ml of dichloromethane and ruthenium 2.25 ml of triethylamine and the obtained thick suspension was between 2 Stir at 0 - 2 5 °C for 1 hour. The suspension thus obtained was added to a solution of 2.3 ml of methyl chloroformate in 25 ml of dichloromethane at a temperature of 5-10 °C. The reaction mixture obtained was stirred at a temperature of 20-25 < t for 3 hours' and then extracted with 3 x 150 ml (150 g) of distilled water. The organic phase was evaporated in vacuo and the residue was crystallised from methanol. In this way -12- 201144289 obtained 4. 5 grams of the title product. Yield: 7 2 % Melting point: 1 4 3 - 1 4 7. (: Example 2 trans N-(4-{2-[4-(2,3-dichlorophenylpiperazin-1-yl)hexyl)-carbamic acid isopropyl ester will be 6.45 g (0.015 mol) The second compound of formula (111) is added to 125 ml of dichloromethane and 12.25 ml of triethylamine. The thick suspension obtained is stirred at a temperature between 2 〇 25 ° C. The solution was added to a solution of 3.7 g (〇.〇3 mol) of isopropyl chloroformate in 30· at a temperature of 5-1 Torr. The mixture was stirred at a temperature between 20 and 25 °C. After 3 hours and 150 ml (150 g) of distilled water was extracted. The organic phase was taken in vacuo and the residue obtained was recrystallized from isopropanol. In this way 4.4 g of the title compound. Yield: 6 7 %

熔點:1 2 8 -1 3 1 °C 實例3 反式4-{2-[4-(2,3-—氣苯基)·峨哄·卜基卜乙 二甲基胺甲醯基環己胺 將6.45公克(〇_〇15莫耳)式(m)化合物之二 加至125毫升二氯甲烷# 12.25毫升三乙胺的混 L基卜環 I酸鹽添 (物中且 拌1小 E升甲苯 將反應 著以3x ?中蒸發 :中獲得 } -Ν,Ν- 酸鹽添 物中且 '13- 201144289 將所獲得的濃稠懸浮液在介於20-25°C之溫度下攪 時。將懸浮液經1小時添加至介於-5 ·( -1 0 ) °C之溫 50毫升二氯甲烷中的4.9公克雙(三氯甲基)碳酸醋 中。將所獲得的反應混合物添加至介於0-(-1〇)。(: 下冷卻之1〇〇毫升異丙醇(IPA)中的13公克二甲 (40毫升,0.12莫耳)中,將此期間的反應混合物溫 在〇°C以下。在介於0-(-5) °C之溫度下攪拌30分鐘 將1 00毫升蒸餾水添加至攪拌下的反應混合物中。 水相的pH藉由添加濃縮的氫氯酸調整至7 - 8且將 合物體積在真空下濃縮至〗30毫升》將額外70毫 水添加至所獲得的反應混合物中且將混合物在真空 至170毫升。將懸浮液在20-25 °C下攪拌1小時且 得的產物以過濾分離。在此方式中獲得6.6公克標 物。 產率:9 5 % 熔點:2 0 8 - 2 1 1 t 實例4 反式4-{2-[4-(2,3-二氯苯基)-哌哄-1-基]-乙基 二甲基胺甲醯基環己胺 將 4.4 公克(0.011 莫耳)反式 N-(4-{2-[4-(2,3-基)-哌哄-1-基]-乙基}-環己基)-胺基甲酸甲酯溶解 毫升二氯甲烷中。將所獲得的溶液添加至介於〇-1 之溫度下冷卻之1〇〇毫升異丙醇(IPA)中的13公克 伴1小 度下於 之溶液 之溫度 胺溶液 度保持 之後, 接著將 反應混 升蒸餾 下濃縮 將所獲 題化合 } -Ν,Ν- 二氯苯 在 120 :-l〇)°C 二甲胺 -14- 201144289 溶液(100毫升,0·3莫耳)中,將此期間的反應混合物溫度 保持在以下。在介於0-(-5 )°C之溫度下攪拌30分鐘之 後,將100毫升蒸餾水添加至攪拌下的反應混合物中。接 著將水相的pH藉由添加濃縮的氫氯酸調整至7-8且將反 應混合物體積在真空下濃縮至100毫升。將額外70毫升 蒸餾水添加至所獲得的反應混合物中且將混合物在真空下 濃縮至120毫升。將懸浮液在20-25 °C下攪拌1小時且將 所獲得的產物以過濾分離。在此方式中獲得4.3公克標題 化合物β 產率:9 5 %Melting point: 1 2 8 -1 3 1 °C Example 3 Trans 4-{2-[4-(2,3--Phenylphenyl)·峨哄·Bujib Ethyldimethylamine-Methylthiol The amine is added to 6.45 g (〇_〇15 mol) of the compound of the formula (m) to 125 ml of dichloromethane # 12.25 ml of triethylamine mixed with L-bib ring I acid salt (and mixed with 1 small E The liter of toluene will react with evaporation in 3x?: in the -Ν, Ν-acidate and '13- 201144289. The thick suspension obtained will be stirred at a temperature between 20-25 °C. The suspension was added to 4.9 g of bis(trichloromethyl)carbonate in a temperature of 50 ml of dichloromethane at -5 · ( -1 0 ° C) over 1 hour. The obtained reaction mixture was added. Up to 0-(-1〇). (: 13 g of dimethyl (40 ml, 0.12 mol) in 1 mL of isopropanol (IPA) under cooling, the reaction mixture was warmed during this period. 〇 ° C or less. Add 100 ml of distilled water to the stirred reaction mixture at a temperature of 0-(-5) ° C for 30 minutes. The pH of the aqueous phase is adjusted by adding concentrated hydrochloric acid to 7 - 8 and concentrate the volume under vacuum to 〖30 ml An additional 70 milliliters of water was added to the obtained reaction mixture and the mixture was vacuumed to 170 ml. The suspension was stirred at 20-25 ° C for 1 hour and the product obtained was isolated by filtration.克克物物. Yield: 9 5 % Melting point: 2 0 8 - 2 1 1 t Example 4 trans 4-{2-[4-(2,3-dichlorophenyl)-piperidin-1-yl] -ethyl dimethylamine-mercaptocyclohexylamine 4.4 g (0.011 mol) trans N-(4-{2-[4-(2,3-yl)-piperidin-1-yl]- Ethyl ethyl}-cyclohexyl)-carbamic acid methyl ester was dissolved in dichloromethane. The obtained solution was added to 1 liter of isopropanol (IPA) cooled at a temperature of 〇-1. After the gram of the solution is maintained at a temperature of 1 degree, the amine solution is maintained, and then the reaction is concentrated and concentrated under distillation to obtain the title compound: -Ν, Ν-dichlorobenzene at 120:-l〇) ° C In the amine-14- 201144289 solution (100 ml, 0.3 mol), the temperature of the reaction mixture during this period was kept below. After stirring at a temperature of 0-(-5) ° C for 30 minutes, 100 ML distilled water is added to the reaction mixture under stirring The pH of the aqueous phase was then adjusted to 7-8 by the addition of concentrated hydrochloric acid and the reaction mixture volume was concentrated to 100 mL under vacuum. An additional 70 mL of distilled water was added to the obtained reaction mixture and The mixture was concentrated to 120 mL under vacuum. The suspension was stirred at 20-25 ° C for 1 hour and the obtained product was isolated by filtration. In this way, 4.3 g of title is obtained. Compound β Yield: 9 5 %

熔點:2 0 8 - 2 1 1 °C 實例5 反式4-{2-[4-(2,3-二氯苯基)-峨哄-1-基]-乙基卜n,n_ 二甲基胺甲醯基環己胺鹽酸鹽 將6.45公克(0.015莫耳)式(III)化合物之二鹽酸鹽添 加至125毫升二氯甲烷與12.25毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於20-2 5 °C之溫度下潰泮i /J、 時。將懸浮液經1小時添加至介於-5 - (-1 〇)。〇之溫度下於 50鼋升二氯甲烷中的4.9公克雙(三氯甲基)碳酸酯之溶液 中。將所獲得的反應混合物添加至介於〇_(_1〇rc之溫度 下冷卻之100毫升異丙醇(IP A)中的13公克二甲胺溶液 (4〇毫升’ 0.12莫耳)中’將此期間的反應混合物溫度保持 在〇°C以下。在介於0-(-5)t:之溫度下攪拌3〇分鐘之後, -15- 201144289 將100毫升蒸餾水添加至搅拌下的反應混合物中。接著將 水相的ρ Η藉由添加濃縮的氫氯酸調整至2 · 3且將反應混 合物濃縮至1 3 0毫升,添加額外7 0毫升蒸餾水且將混合 物濃縮至17〇毫升。將懸浮液在20-2 5 °C下攪拌1小時且 將所獲得的產物以過濾分離。在此方式中獲得6.7公克標 題化合物。 產率:9 6 %Melting point: 2 0 8 - 2 1 1 °C Example 5 trans 4-{2-[4-(2,3-dichlorophenyl)-indol-1-yl]-ethyl bn, n_ dimethyl Baseline methionylcyclohexylamine hydrochloride 6.45 g (0.015 mol) of the dihydrochloride salt of the compound of formula (III) is added to a mixture of 125 ml of dichloromethane and 12.25 ml of triethylamine and the obtained When the thick suspension is collapsed at a temperature between 20 and 2 ° C, i / J. The suspension was added over 1 hour to between -5 - (-1 〇). A solution of 4.9 g of bis(trichloromethyl) carbonate in 50 liters of dichloromethane was added at a temperature of hydrazine. The obtained reaction mixture was added to a solution of 13 g of dimethylamine (4 ml of '0.12 mol) in 100 ml of isopropanol (IP A) cooled at a temperature of 〇 ( 将 将The temperature of the reaction mixture during this period was kept below 〇 ° C. After stirring at a temperature of 0-(-5) t: for 3 minutes, -15-201144289 100 ml of distilled water was added to the stirred reaction mixture. The ρ 水 of the aqueous phase was then adjusted to 2 · 3 by the addition of concentrated hydrochloric acid and the reaction mixture was concentrated to 1 30 mL, additional 70 mL of distilled water was added and the mixture was concentrated to 17 mL. Stirring at 20 to 5 ° C for 1 hour and the obtained product was isolated by filtration. 6.7 g of the title compound was obtained in this manner. Yield: 9 6 %

熔點:2 2 1 - 2 2 4 °C 實例6 反式 4-{2·[4-(2,3-二氯苯基)-哌哄-1-基]-乙基}-N,N-二甲基胺甲醯基環己胺鹽酸鹽 將6.72公克(0.015莫耳)式(III)化合物之二鹽酸鹽單 水合物添加至125毫升二氯甲烷與12.25毫升三乙胺的混 合物中且將所獲得的濃稠懸浮液在介於20-25 °C之溫度下 攪拌1小時。將懸浮液經1小時添加至介於-5-(-1 0)°C之 溫度下於50毫升二氯甲烷中的4.9公克雙(三氯甲基)碳酸 酯之溶液中。將所獲得的反應混合物添加至介於0-(-10) 乞之溫度下冷卻之100毫升異丙醇(IPA)中的13公克二甲 胺溶液(4〇毫升,0.12莫耳)中,將此期間的反應混合物溫 度保持在0°C以下。在介於0-(-5)t之溫度下攪拌30分鐘 之後’將1 00毫升蒸餾水添加至反應混合物中且將水相的 pH藉由添加濃縮的氫氯酸調整至2_3。將反應混合物在真 空下濃縮至1 30毫升,接著添加額外70毫升水且將混合 -16- 201144289 物濃縮至170毫升。將懸浮液在介於20-25 °C之溫度下攪 拌1小時且將所獲得的產物以過濾分離。在此方式中獲得 6.7公克標題化合物。 產率:9 6 %Melting point: 2 2 1 - 2 2 4 °C Example 6 trans 4-{2·[4-(2,3-dichlorophenyl)-piperidin-1-yl]-ethyl}-N,N- Dimethylamine-m-decylcyclohexylamine hydrochloride 6.72 g (0.015 mol) of the dihydrochloride monohydrate of the compound of formula (III) was added to a mixture of 125 ml of dichloromethane and 12.25 ml of triethylamine. The thick suspension obtained was stirred at a temperature between 20 and 25 ° C for 1 hour. The suspension was added over 1 hour to a solution of 4.9 g of bis(trichloromethyl)carbonate in 50 ml of dichloromethane at a temperature of -5-(-1) °C. The obtained reaction mixture was added to a solution of 13 g of dimethylamine (4 ml, 0.12 mol) in 100 ml of isopropanol (IPA) cooled at a temperature of 0-(-10) Torr. The temperature of the reaction mixture during this period was kept below 0 °C. After stirring at a temperature of 0-(-5)t for 30 minutes, 100 ml of distilled water was added to the reaction mixture and the pH of the aqueous phase was adjusted to 2 to 3 by adding concentrated hydrochloric acid. The reaction mixture was concentrated to a volume of 1 30 mL under vacuum, then an additional 70 mL of water was then weighed and concentrated -16 - 201144289 was concentrated to 170 ml. The suspension was stirred at a temperature between 20 and 25 ° C for 1 hour and the obtained product was isolated by filtration. In this manner, 6.7 g of the title compound was obtained. Yield: 9 6 %

熔點:2 2 1 - 2 2 4 °C 實例7 1-反式{4-[2-[4-(2,3-二氯苯基)-哌哄-1-基]-乙基]-環 己基}尿素 將6.45公克(0.015莫耳)式(in)化合物之二鹽酸鹽添 加至160毫升二氯甲烷與12.8毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於2 0 - 2 5 °C之溫度下攪拌1小 時。將懸浮液經1小時添加至介於_ 5 - (-1 〇) t之溫度下於 75毫升二氯甲烷中的4.9公克雙(三氯甲基)碳酸酯之溶液 中。將所獲得的反應混合物添加至介於〇 _ (_丨〇)艺之溫度 下冷卻之甲醇中的氨溶液(11〇毫升,17公克/100毫升) 中’將此期間的反應混合物溫度保持在0 以下。在介於 〇-(-5)C之溫度下攪拌30分鐘之後’將反應混合物在真空 下濃縮至1 〇〇毫升’接著添加8 00毫升蒸餾水。將懸浮液 在2 0 - 2 5 °C下攪拌1小時且將所獲得的產物以過濾分離。 在此方式中獲得5.6公克標題化合物。 產率:9 4 % 熔點:22 1 -224T: -17- 201144289 實例8 反式Ν-{4-{2-[4-(2,3·二氯苯基)-哌哄-1-基]-乙基卜環 己基}-N’_甲基尿素鹽酸鹽 將6.45公克(0.015莫耳)式(III)化合物之二鹽酸鹽添 加至125毫升二氯甲烷與12.25毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於2 0 - 2 5 °C之溫度下攪拌1小 時。將懸浮液經1小時添加至介於-5 - (-1 0) °C之溫度下於 50毫升二氯甲烷中的4_9公克雙(三氯甲基)碳酸酯之溶液 中。將所獲得的反應混合物添加至介於〇 - (-1 〇) 之溫度 下冷卻之異丙醇(IPA)中的甲胺溶液(60毫升,12.5公克 /1 0 0毫升)中,將此期間的反應混合物溫度保持在〇 〇c以 下。在介於0-(-5) °C之溫度下攪拌30分鐘之後,將130 毫升蒸餾水添加至反應混合物中,接著將水相的pH藉由 添加濃縮的氫氯酸調整至2-3。將反應混合物在真空中濃 縮至1 20毫升且添加額外70毫升蒸餾水。將懸浮液在介 於20-25 °C之溫度下攪拌1小時且將所獲得的產物以過濾 分離。在此方式中獲得6.6公克標題化合物。 產率:9 5 %Melting point: 2 2 1 - 2 2 4 ° C Example 7 1-trans {4-[2-[4-(2,3-dichlorophenyl)-piperidin-1-yl]-ethyl]-cyclo Hexyl}urea 6.45 g (0.015 mol) of the dihydrochloride salt of the compound (in) was added to a mixture of 160 ml of dichloromethane and 12.8 ml of triethylamine and the obtained thick suspension was between 2 Stir at 0 - 2 5 °C for 1 hour. The suspension was added over 1 hour to a solution of 4.9 g of bis(trichloromethyl)carbonate in 75 ml of dichloromethane at a temperature of _ 5 - (-1 〇) t. The obtained reaction mixture was added to an ammonia solution (11 mL, 17 g/100 ml) in methanol cooled at a temperature of 〇_ (丨〇), and the temperature of the reaction mixture during this period was kept at 0 or less. After stirring for 30 minutes at a temperature of 〇-(-5)C, the reaction mixture was concentrated under vacuum to 1 〇〇 ml, followed by the addition of 800 ml of distilled water. The suspension was stirred at 20 - 25 ° C for 1 hour and the obtained product was isolated by filtration. In this manner, 5.6 g of the title compound was obtained. Yield: 9 4 % Melting point: 22 1 -224T: -17- 201144289 Example 8 trans Ν-{4-{2-[4-(2,3·dichlorophenyl)-piperidin-1-yl] -ethylcyclohexyl}-N'-methyl urea hydrochloride 6.45 g (0.015 mol) of the dihydrochloride salt of the compound of formula (III) was added to a mixture of 125 ml of dichloromethane and 12.25 ml of triethylamine. The obtained thick suspension was stirred at a temperature of 20 to 25 ° C for 1 hour. The suspension was added over 1 hour to a solution of 4-9 g of bis(trichloromethyl)carbonate in 50 ml of dichloromethane at a temperature of -5 - (-1 0) °C. The obtained reaction mixture was added to a methylamine solution (60 ml, 12.5 g/100 ml) in isopropanol (IPA) cooled at a temperature of 〇-(-1 〇), during which time The temperature of the reaction mixture is kept below 〇〇c. After stirring at a temperature of 0-(-5) °C for 30 minutes, 130 ml of distilled water was added to the reaction mixture, and then the pH of the aqueous phase was adjusted to 2-3 by adding concentrated hydrochloric acid. The reaction mixture was concentrated to 120 mL in vacuo and an additional 70 mL distilled water was added. The suspension was stirred at a temperature of 20-25 ° C for 1 hour and the obtained product was separated by filtration. In this way 6.6 g of the title compound was obtained. Yield: 9 5 %

熔點:230-255 °C 實例9 反式N-{4-{2-[4-(2,3-二氯苯基)_哌哄基]•乙基卜環 己基}尿素鹽酸鹽 將ό·45公克(0.015莫耳)式(m)化合物之二鹽酸鹽添 -18- 201144289 加至160毫升二氯甲烷與12.8毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於20-25t之溫度下攪拌1小 時。將懸浮液經1小時添加至介於-5-(-10)°C之溫度下於 75毫升二氯甲烷中的4.9公克雙(三氯甲基)碳酸酯之溶液 中。將所獲得的反應混合物添加至介於0-(-10)°C之溫度 下冷卻之甲醇中的氨溶液(110毫升,17公克/100毫升) 中,將此期間的反應混合物溫度保持在0°c以下。在〇-1 0 °C下攬拌30分鐘之後,將反應混合物在真空中濃縮至20 毫升,接著添加140毫升蒸餾水。將水相的pH藉由添加 濃縮的氫氯酸調整至2-3。將懸浮液在介於20-25 t之溫 度下攪拌1小時且將所獲得的產物以過濾分離。在此方式 中獲得5 · 8 6公克標題化合物。 產率:90% 熔點:2 5 0 - 2 5 3 °C (分解) 實例1 〇 反式N-{4-{2-[4-(2,3 -二氯苯基)-哌哄-1-基]-乙基卜環 己基}-嗎啉-4-碳酸醯胺 將6.45公克(0.015莫耳)式(ill)化合物之二鹽酸鹽添 加至125毫升二氯甲烷與12.25毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於2 0 -2 5 °C之溫度下攪拌1小 時。將懸浮液經1小時添加至介於-5 - (-1 〇) °C之溫度下於 50毫升二氯甲烷中的4.9公克雙(三氯甲基)碳酸酯之溶液 中。將因此獲得的反應混合物添加至介於〇 _ (_ ) °C之溫 -19- 201144289 度下冷卻之70毫升異丙醇(IPA)中的10.44公克(0.12莫 耳)嗎啉溶液中,將此期間的反應混合物溫度保持在〇 t 以下。在0-10 °C下攪拌30分鐘之後,將100毫升蒸餾水 添加至搅拌下的反應混合物中且將水相的pH藉由添加濃 縮的氫氯酸調整至7-8。將反應混合物在真空下濃縮至 1 3 0毫升且添加額外1 00毫升蒸餾水。將反應混合物體積 在真空中減少至150毫升。將懸浮液在介於20-25 °C之溫 度下攪拌1小時且將所獲得的產物以過濾分離。在此方式 中獲得6.55公克標題化合物。 產率:9 3 % 熔點:204-206°C (分解) 實例1 1 反式N-{4-{2-[4-(2,3-二氯苯基)-哌畊-1-基]-乙基卜環 己基}-嗎啉-4-碳酸醯胺鹽酸鹽 將6.45公克(〇.〇15莫耳)式(in)化合物之二鹽酸鹽添 加至125毫升二氯甲烷與12.25毫升三乙胺的混合物中且 將所獲得的濃稠懸浮液在介於2 0 - 2 5 °C之溫度下攪拌1小 時。將懸浮液經1小時添加至介於-5 - (-1 0) °C之溫度下於 50毫升二氯甲烷中的4.9公克雙(三氯甲基)碳酸酯之溶液 中。將所獲得的反應混合物添加至冷卻至介於〇-(-1 〇)。〇 之溫度的70毫升異丙醇(IPA)中的10.44公克(0.12莫耳) 嗎啉溶液中’將此期間的反應混合物溫度保持在〇 t以 下。在0-10 °C下攪拌30分鐘之後,將100毫升蒸餾水添 •20- 201144289 加至攪拌下的反應混合物中,接著將水相的pH調整至2-3。將反應混合物在真空下濃縮至130毫升且添加另外 100毫升蒸餾水。接著將反應混合物體積在真空下減少至 15〇毫升。將懸浮液在介於20-25 °C之溫度下攪拌1小時 且將所獲得的產物以過濾分離。在此方式中獲得7 . 1公克 標題產物。 產率:94% 熔點:1 9 7 t (分解) -21 -Melting point: 230-255 °C Example 9 trans N-{4-{2-[4-(2,3-dichlorophenyl)-piperidinyl]•ethylbucyclohexyl}urea hydrochloride · 45 g (0.015 mol) of the dihydrochloride salt of the compound of formula (m) -18- 201144289 was added to a mixture of 160 ml of dichloromethane and 12.8 ml of triethylamine and the obtained thick suspension was introduced. Stir at a temperature of 20-25 t for 1 hour. The suspension was added over 1 hour to a solution of 4.9 g of bis(trichloromethyl)carbonate in 75 ml of dichloromethane at a temperature of -5 - (-10) °C. The obtained reaction mixture was added to an ammonia solution (110 ml, 17 g/100 ml) in methanol cooled at a temperature of 0-(-10) ° C, and the temperature of the reaction mixture during this period was maintained at 0. Below °c. After stirring for 30 minutes at 〇-1 0 ° C, the reaction mixture was concentrated to 20 mL in vacuo, then 140 ml distilled water was added. The pH of the aqueous phase was adjusted to 2-3 by the addition of concentrated hydrochloric acid. The suspension was stirred at a temperature of 20-25 t for 1 hour and the obtained product was isolated by filtration. In this way, 5 · 8 6 g of the title compound was obtained. Yield: 90% Melting point: 2 5 0 - 2 5 3 ° C (decomposition) Example 1 〇trans N-{4-{2-[4-(2,3-dichlorophenyl)-piperidin-1 -yl]-ethylcyclohexyl}-morpholine-4-guanidiniumamine 6.45 g (0.015 mol) of the dihydrochloride salt of the compound (ill) was added to 125 ml of dichloromethane and 12.25 ml of triethylamine. The resulting thick suspension was stirred for 1 hour at a temperature between 20 and 25 °C. The suspension was added over 1 hour to a solution of 4.9 g of bis(trichloromethyl)carbonate in 50 ml of dichloromethane at a temperature of -5 - (-1 〇) °C. The reaction mixture thus obtained is added to a solution of 10.44 g (0.12 mol) of morpholine in 70 ml of isopropanol (IPA) cooled at -19_(_) °C of -19-201144289 °C. The temperature of the reaction mixture during this period was kept below 〇t. After stirring at 0 to 10 ° C for 30 minutes, 100 ml of distilled water was added to the stirred reaction mixture and the pH of the aqueous phase was adjusted to 7-8 by the addition of concentrated hydrochloric acid. The reaction mixture was concentrated to 130 mL under vacuo and an additional 100 mL distilled water was then weighed. The reaction mixture volume was reduced to 150 ml in vacuo. The suspension was stirred at a temperature between 20 and 25 ° C for 1 hour and the obtained product was isolated by filtration. In this manner, 6.55 g of the title compound was obtained. Yield: 9 3 % Melting point: 204-206 ° C (decomposition) Example 1 1 trans N-{4-{2-[4-(2,3-dichlorophenyl)-piped-1-yl] -ethylbucyclohexyl}-morpholin-4-guanidinium hydrochloride hydrochloride 6.45 g (〇.〇15 mol) of the compound (in) dihydrochloride salt was added to 125 ml of dichloromethane and 12.25 ml. The mixture of triethylamine was stirred and the resulting suspension was stirred at a temperature of 20 to 25 ° C for 1 hour. The suspension was added over 1 hour to a solution of 4.9 g of bis(trichloromethyl)carbonate in 50 ml of dichloromethane at a temperature of -5 - (-1 0) °C. The obtained reaction mixture was added to cool to 〇-(-1 〇). The temperature of the reaction mixture during this period was kept below 10.4 in a solution of 10.44 g (0.12 mol) of morpholine in 70 ml of isopropanol (IPA) at 温度. After stirring at 0 to 10 ° C for 30 minutes, 100 ml of distilled water was added to add 20-201144289 to the stirred reaction mixture, and then the pH of the aqueous phase was adjusted to 2-3. The reaction mixture was concentrated to 130 mL under vacuum and additional 100 mL distilled water was added. The volume of the reaction mixture was then reduced to 15 〇 ml under vacuum. The suspension was stirred at a temperature between 20 and 25 ° C for 1 hour and the obtained product was isolated by filtration. In this way, 7.1 g of the title product was obtained. Yield: 94% Melting point: 1 9 7 t (decomposition) -21 -

Claims (1)

201144289 七、申請專利範圍 一種製備通式(I)化合物及其鹽酸鹽及/或水合物及/ 或溶劑合物的方法’201144289 VII. Scope of Application Patent A method for preparing a compound of the formula (I) and its hydrochloride and/or hydrate and/or solvate 其中Ri及R2獨立代表 -氫,或 -以芳基隨总地取代之直鏈或支鏈CU6烷基,或 -含有個雙鍵之C2.7烯基,或 -以一或多個C,-6烷氧基、三氟-(:^烷氧基、 Ci-6-院氧基缴基、C|-6院酿基、芳基、C|_6院硫基、齒素 或氛基隨意地取代之單環、雙環或三環芳基,或 -隨意地經取代之單環、雙環或三環c3_14環烷 基, -Ri及R2與鄰接的氮一起形成隨意地經取代之飽 和或不飽和單環或雙環雜環狀環,其可含有選自氧、氮或 硫原子之另外的雜原子, 該方法的特徵在於將式(ΠΙ)之反式4-{2-[4-(2,3·二氯 苯基)-哌哄-1-基]-乙基}-環己胺或其鹽或水合物或溶劑合 物 -22- 201144289 h2nWherein Ri and R2 independently represent -hydrogen, or - a straight or branched CU6 alkyl group substituted with an aryl group in total, or - a C2.7 alkenyl group having a double bond, or - one or more C, -6 alkoxy, trifluoro-(: alkoxy, Ci-6-homoxyl, C|-6 broth, aryl, C|_6 thiol, dentate or aryl Substituted monocyclic, bicyclic or tricyclic aryl, or optionally substituted monocyclic, bicyclic or tricyclic c3_14 cycloalkyl, -Ri and R2 together with adjoining nitrogen form randomly substituted or not a saturated monocyclic or bicyclic heterocyclic ring which may contain additional heteroatoms selected from oxygen, nitrogen or sulfur atoms, the process being characterized by trans- 4-{2-[4-(2) of formula (ΠΙ) ,3·dichlorophenyl)-piperazin-1-yl]-ethyl}-cyclohexylamine or a salt or hydrate or solvate thereof-22- 201144289 h2n ClCl (Hi) 在鹼的存在下溶解或懸浮在惰性溶劑中 接著添加通式(VI)之碳酸衍生物 R-O-CO-Z (VI) 其中R爲直鏈或支鏈(:,.6烷基、部分或完全鹵化之Cm 烷基或苯基,Z爲-〇-R或-X,其中R係如上所述,X爲 鹵素,及 將所獲得的通式(IV)化合物 〇(Hi) dissolved or suspended in an inert solvent in the presence of a base followed by the addition of the carbonic acid derivative RO-CO-Z (VI) of the formula (VI) wherein R is a linear or branched (:, .6 alkyl group, Partially or completely halogenated Cm alkyl or phenyl, Z is -〇-R or -X, wherein R is as defined above, X is a halogen, and the obtained compound of the formula (IV) is 〇 (IV) (其中R係如上所述)當場或隨意地呈分離狀態與通式(V) 之胺 Ri NH / r2. (其中Rt及R·2係如上所述)反應’獲得通式⑴化合物,及 接著隨意地形成其鹽酸鹽及/或水合物及/或溶劑合 -23- 201144289 物。 2. 根據申請專利範圍第1項之方法,其中該通式(VI) 之碳酸衍生物爲氯甲酸酯或雙(H氯甲基)碳酸酯。 3. 根據申請專利範圍第1項之方法,其中該通式(IV) 與(V)化合物的反應係以不分離通式(IV)化合物而當場進 行。 -24- 201144289 四 指定代表圖: (一) 本案指定代表圖為:無 (二) 本代表圖之元件符號簡單說明:無 201144289 五、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:式(I)(IV) (wherein R is as described above) is reacted in situ or optionally in a separated state with an amine of the formula (V), Ri NH / r2. (wherein Rt and R.2 are as described above), to obtain a compound of the formula (1) And then optionally form its hydrochloride and / or hydrate and / or solvent -23- 201144289. 2. The method of claim 1, wherein the carbonic acid derivative of the formula (VI) is a chloroformate or a bis(H chloromethyl) carbonate. 3. The method of claim 1, wherein the reaction of the compound of the formula (IV) with the compound (V) is carried out on the spot without isolating the compound of the formula (IV). -24- 201144289 Four designated representative maps: (1) The representative representative of the case is: No (2) The symbol of the representative figure is simple: No 201144289 V. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention. :Form (I)
TW099143483A 2009-12-17 2010-12-13 Novel process for the preparation of piperazine compounds and hydrochloride salts thereof TW201144289A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900790A HUP0900790A2 (en) 2009-12-17 2009-12-17 A new process for the preparation of piperazine and their hydrochloric salts

Publications (1)

Publication Number Publication Date
TW201144289A true TW201144289A (en) 2011-12-16

Family

ID=89989448

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099143483A TW201144289A (en) 2009-12-17 2010-12-13 Novel process for the preparation of piperazine compounds and hydrochloride salts thereof

Country Status (3)

Country Link
HU (1) HUP0900790A2 (en)
TW (1) TW201144289A (en)
WO (1) WO2011073705A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104140421B (en) 2013-05-08 2017-04-05 上海医药工业研究院 Benzo isothiazole compound and the application in antipsychotic drug is prepared
WO2018229794A1 (en) * 2017-06-13 2018-12-20 Cipla Limited Amorphous form of cariprazine
CN108586389B (en) * 2018-06-29 2020-06-12 成都福柯斯医药技术有限公司 Method for synthesizing Carilazine
CN110372557B (en) * 2019-08-06 2021-05-18 上海勋和医药科技有限公司 Cyclohexanamines D3/D2Partial receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0800765A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives

Also Published As

Publication number Publication date
WO2011073705A1 (en) 2011-06-23
HUP0900790A2 (en) 2011-09-28
HU0900790D0 (en) 2010-03-01

Similar Documents

Publication Publication Date Title
TWI460164B (en) Process for the preparation of piperazine compounds and hydrochloride salts thereof
JP2012512861A5 (en)
ES2393692T3 (en) Method for the preparation of dabigatran and its intermediates
TWI454464B (en) Process for the preparation of piperazine derivatives
BR112013000085B1 (en) Processes for the preparation of optically active diamine derivative salt
JP2016147807A (en) Hydroxamic acid derivative and salt thereof
TW201144289A (en) Novel process for the preparation of piperazine compounds and hydrochloride salts thereof
US20140155614A1 (en) Pharmaceutical intermediates and process for the preparation thereof
TWI233924B (en) Process for trans-4-amino-1-cyclohexane carboxylic acid derivatives
KR100859106B1 (en) Method for preparing mesylate of piperazine derivatives
BRPI0608914A2 (en) 3,4 dihydro-benzo [e] [1,3] oxazin-2-ones
EP2142507A1 (en) Process for the preparation of sorafenib and salts thereof
JP2005255630A (en) Ethyl trans-4-amino-1-cyclohexanecarboxylate salt and method for producing the same
WO2002076958A1 (en) Process for producing 5-substituted oxazole compounds and 5-substituted imidazole compounds
TWI310380B (en) Process for the preparation of mesylates of piperazine derivatives
JP2006182740A (en) Method for preparing glycidyl sulfonate
JP2007197397A (en) Method for producing multi-substituted ethylenediamine derivative
HU213116B (en) A new process for producing n``-cyano-n`-(4-pyridyl)-n-(1,2,2-trimethyl-propyl)-guanidine
JP2018197206A (en) Manufacturing method of azilsartan synthetic intermediate
JP2005060381A (en) Method for producing amide compound